Selection of Vibrio parahaemolyticus isolates as potential vaccine candidates in Litopenaeus vannamei Authors: Ardana Kurniaji, Sri Nuryati, Sukenda Sukenda, Alimuddin Alimuddin, Hasan Nasrullah Published: 2026 ABSTRACT Highlights•Local Vibrio parahaemolyticus AHPND isolates differed in virulence and genetic characteristics.•BYW and IND isolates showed relatively higher pathogenicity and carried both pirA and pirB genes.•Innate immune responses varied among vaccines prepared from different isolates.•The BYW-derived inactivated vaccine improved survival and conferred cross protection against heterologous isolates.•Vaccine performance may be influenced by the characteristics of the selected isolate.Keywords: AHPND, Immunity, Shrimp vaccination, Vaccine candidate, Vibrio parahaemolyticus Introduction Pacific white shrimp (L. vannamei) aquaculture remains severely threatened by Acute Hepatopancreatic Necrosis Disease (AHPND), a condition caused by the bacterium V. parahaemolyticus (VpAHPND) [1,2]. This pathogen produces Photorhabdus insect-related (Pir) toxins, PirA and PirB, which are encoded by the pVA1 plasmid and are capable of horizontal transfer among Vibrio species [[3], [4], [5]]. These toxin components assemble into the binary PirAB complex, thereby enhancing bacterial virulence [[6], [7], [8]]. The PirAB toxin induces degeneration of hepatopancreatic tubular epithelial cells, ultimately resulting in mass mortality in shrimp aquaculture systems [9,10]. Mortality rates can reach up to 100% during the early culture phase, typically within 20–30 days post-stocking [11,12]. Numerous studies have documented the substantial economic losses associated with AHPND in the Pacific white shrimp aquaculture industry, underscoring the urgent need for the development of effective and innovative control strategies [[13], [14], [15], [16], [17], [18], [19], [20], [21], [22]]. Vaccination has been recognized as a promising strategy to mitigate VpAHPND infection in Pacific white shrimp (L. vannamei) [23]. Although shrimp lack an antibody-based adaptive immune system as observed in fish, previous studies have suggested that protective efficacy in shrimp may involve innate immune priming, a phenomenon that has been described as trained immunity [24]. Previous studies have proposed that trained immunity involves functional reprogramming of innate immune responses, including enhanced phagocytic activity, increased production of antimicrobial effectors, modulation of pattern recognition receptors, and epigenetic modifications that serve as a form of systemic immune memory [25]. Several studies have reported enhanced protection upon secondary exposure in shrimp, a phenomenon considered consistent with innate immune memory, with protective effects ranging from 7 to 90 days post-vaccination, as evidenced by challenge tests using Vibrio spp. [[26], [27], [28], [29], [30]]. Whole-cell inactivated vaccines are among the most widely applied vaccine types in aquaculture due to their high safety profile, low production cost, and relatively simple development and manufacturing processes. In addition, they exhibit greater stability during storage, transportation, and field application, making them a suitable choice for use in the present study [[31], [32], [33]]. Several studies have reported enhanced immune responses and improved survival following vaccination with inactivated Vibrio spp. in various shrimp species, including Pacific white shrimp and black tiger shrimp [[34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51]]. The effectiveness of inactivated vaccines in eliciting protective innate immune responses is strongly influenced by antigen compatibility. Several studies have demonstrated that antigenicity derived from homologous pathogenic bacteria is superior to that of heterologous bacteria and immunostimulants [48,49,52]. Previous studies have described trained immunity as a form of innate immune memory that provides enhanced protection against subsequent infections [53]. The selection of bacterial isolates, therefore, represents a critical initial step in shrimp vaccine development, as it is closely associated with their capacity to induce protective innate immune responses [50,54]. Several studies have reported that bacterial virulence factors can serve as key criteria in selecting vaccine candidates [55]. Bacteria with higher pathogenicity generally express major virulence factors that function as immunogenic antigens, thereby inducing stronger immune responses [56,57]. However, the relationship between virulence level, which determines bacterial pathogenicity, and its immunogenic potential in conferring protection remains to be fully elucidated. In their study, Hirono et al. [23] reported that among three VpAHPND isolates prepared as inactivated vaccines, only one strain conferred effective protection in Pacific white shrimp. This finding demonstrates that protective antigenicity is not uniformly present across all VpAHPND isolates. Genetic variability among isolates is presumed to be a major factor underlying differences in antigenic determinants and pathogenic potential [58,59]. Therefore, investigations on the virulence level of VpAHPND and its protective efficacy as a vaccine candidate are necessary. This study aims to identify an optimal VpAHPND bacterial isolate for use as a vaccine candidate in Pacific white shrimp. Materials and methods Experimental animals and rearing conditions Pacific white shrimp (L. vannamei) were reared from the postlarval stage (PL12) to an average body weight of approximately 5 g. Postlarvae were obtained from domesticated F1 broodstock. They were confirmed to be non-genetically modified organisms (non-GMO), antibiotic-free, and pathogen-free (free of IMNV, WSSV, AHPND, EHP, TSV, IHHNV, and DIV1). Rearing was conducted in controlled tanks at a density of 120 individuals per cubic meter using sterilized water (20 mg L⁻¹ trichloroisocyanuric acid) [60]. Shrimp were fed a commercial diet containing 30% protein, following the feeding regime described by Tacon et al. [61]. Water quality parameters were maintained within optimal ranges, including temperature of 27.2–30.5 °C, dissolved oxygen >5.1 mg L⁻¹, pH 7.8–8.3, nitrite <0.01 mg L⁻¹, nitrate <5 mg L⁻¹, and total ammonia nitrogen <0.01 mg L⁻¹. Water temperature and dissolved oxygen were measured using a YSI dissolved oxygen meter (YSI Inc., Yellow Springs, OH, USA), while pH was determined using a digital pH meter (OEM, China). Nitrite, nitrate, and TAN concentrations were analyzed spectrophotometrically according to APHA [62] at the Water Quality Laboratory, Brackishwater Aquaculture Fisheries Research Center, and Fisheries Extension, Maros, South Sulawesi. Hepatopancreas samples were collected when shrimp reached an approximate body weight of 5 g to confirm the presence of VpAHPND using PCR. Shrimp confirmed to be negative were subsequently used for pathogenicity, immunogenicity, and vaccine protection assays. This study involved the use of animals and was approved by the Research Ethics Committee, Faculty of Medicine, Hasanuddin University, Indonesia (Protocol No. UH25050330; Approval No. 356/UN4.6.4.5.31/PP36/2025). Bacterial isolation and molecular identification Bacterial isolates in this study were sourced from Pacific white shrimp exhibiting clinical signs of VpAHPND infection from various regions in Indonesia. These isolates were cultivated on CHROMagar™ Vibrio (CHROMagar, France) for 24 h at 28–30 °C. Select purple colonies were then transferred into Tryptic Soy Broth (TSB) (HiMedia, India) with 2% NaCl (HiMedia, India) and incubated for a further 24 h at 28–30 °C. Genomic DNA was extracted using the Genomic DNA Mini Kit Bacteria (Geneaid, Taiwan) following the manufacturer's instructions. The AP4 target [63], indicative AHPND, was detected via PCR using 2× MyTaq HS Redmix (Meridian Bioscience, UK). Isolates testing positive for the AP4 PCR assay underwent biochemical identification using the API 20E Reagent Kit (bioMérieux, Durham, USA) and 16S rRNA gene sequencing with primers 27F (5′-AGA GTT TGA TCC TGG CTC AG-3′) and 1492R (5′-CGG TTA CCT TGT TAC GAC TT-3′) [64], performed by 1st BASE DNA Sequencing, Malaysia. The 16S rRNA gene sequences of the BYW, IND, TSK, and STD isolates have been deposited in GenBank under accession numbers PZ623429, PZ623433, PZ705271, and PZ705272, respectively. Phylogenetic analysis was performed using the Maximum Likelihood (ML) method in MEGA version 12.1 on Windows 11, with sequence comparisons against the GenBank database of NCBI (http://www.ncbi.nlm.nih.gov) [65] Experiment 1: pathogenicity assay Pathogenicity testing was conducted to assess the ability of bacterial isolates to cause disease and mortality in Pacific white shrimp. Bacterial isolates previously confirmed positive for the AP4 primer were used in the assay. Rifampicin-resistant mutant strains of V. parahaemolyticus (VpAHPNDRf) were cultured on TCBS agar (HiMedia, India) supplemented with rifampicin (50 µg mL−1), then propagated in TSB supplemented with 2% NaCl and adjusted to a final dose of 106 CFU shrimp−1 according to Hong et al. [58]. The challenge test was performed using shrimp with an average body weight of approximately 5 g, maintained in aerated aquaria under optimal water quality conditions (temperature 28.5–31.5 °C, dissolved oxygen >3.5 mg L⁻¹, pH 7.5–8.5, nitrite 0.01 mg L⁻¹, nitrate <5 mg L⁻¹, and total ammonia nitrogen <0.01 mg L⁻¹). The experiment consisted of four bacterial isolate treatments (TSK, BYW, IND, and STD) and a control treatment injected with phosphate-buffered saline (PBS; NaCl 0.8 g, Na₂HPO₄ 0.15 g, KH₂PO₄ 0.02 g, KCl 0.02 g, distilled water 100 mL, pH 7.3). Bacterial suspensions were administered by intramuscular injection at a dose of 0.1 mL shrimp−1 using a 0.5 mL syringe. The experiment was arranged in a completely randomized design with six replicate aquaria per treatment, each containing 10 shrimp. Four replicate aquaria were used as experimental units for mortality and immune analyses. In contrast, two additional aquaria were used exclusively for destructive sampling and were not included in statistical analyses of mortality. Mortality and clinical signs were recorded every 12 h for 7 days, and MTD was calculated using data from the four observation aquaria, which served as the experimental units for mortality analyses (n = 4 aquaria per treatment). Immune response analyses were conducted using one shrimp sampled from each observation aquarium at every sampling point, with each shrimp representing one biological replicate (n = 4 biological replicates per treatment). Histopathological examination was performed on three shrimp collected from the designated destructive-sampling aquaria at 36 h post-challenge. In contrast, bacterial population analyses used four shrimp collected from the same aquaria at the designated sampling times. Experiment 2: immunogenicity and protection assay Immunogenicity and protection tests were conducted to evaluate the ability of inactivated VpAHPND vaccines to induce immune responses and confer protection in Pacific white shrimp. Vaccines were prepared using the formalin-killed cell (FKC) method according to Hsu et al. [66]. Briefly, bacterial isolates were cultured in TSB supplemented with 2% NaCl, harvested by centrifugation, washed twice with phosphate-buffered saline (PBS), and inactivated with 0.3% formaldehyde (%v/v) (Merck, Germany) for 24 h. The bacterial suspensions were subsequently washed and resuspended in PBS, and complete inactivation was confirmed by the absence of bacterial growth on TCBS agar. Vaccination was performed by intramuscular injection of 0.1 mL bacterial suspension containing 106 CFU-equivalent shrimp−1, after which shrimp were maintained under controlled culture conditions. The experiment consisted of four vaccine treatments (V-BYW, V-IND, V-TSK, and V-STD), a positive control (unvaccinated and challenged), and a negative control (unvaccinated and unchallenged). The protection test was conducted on day 8 post-vaccination using homologous and heterologous VpAHPND challenge at isolate-specific median lethal doses (LD50) estimated using the Reed–Muench [67] method. LD50 determination was performed in a preliminary challenge experiment using five serial bacterial concentrations (103, 104, 105, 106, and 107 CFU shrimp−1). Each concentration was tested in triplicate aquaria containing 10 shrimp per aquarium, and mortality was monitored for 7 days post-challenge. Based on cumulative mortality data, the estimated LD50 values were 5.9 × 104, 1.3 × 105, 2.8 × 105, and 1.2 × 106 CFU shrimp−1 for the BYW, IND, TSK, and STD isolates, respectively. These isolate-specific LD50 doses were subsequently used in homologous and heterologous challenge tests to evaluate vaccine-induced protection. The experiment was arranged in a completely randomized factorial design with two factors (vaccine type and challenge isolate) and four replicate aquaria per treatment, each containing 10 shrimp. Protective efficacy was evaluated following homologous and heterologous challenge tests using survival rate (SR) and relative percent survival (RPS), with replicate aquaria considered the experimental units for protection analyses (n = 4 aquaria per treatment). For immune response analyses, three shrimp were randomly collected from three different replicate aquaria at each sampling point, with each shrimp representing one biological replicate (n = 3 biological replicates per treatment per sampling point). Thus, replicate aquaria served as the experimental units for protection assessments, whereas individual shrimp were used as biological replicates for immune response analyses. Sample collection Hemolymph sampling was conducted before treatment (day 0) and on days 1, 3, 5, and 7 following bacterial infection in the pathogenicity assay or vaccination in the immunogenicity assay. At each sampling point, one shrimp was randomly collected from each of the four observation aquaria, and each shrimp represented one biological replicate. Hemolymph was withdrawn from the ventral sinus using a 0.5 mL syringe and immediately mixed with anticoagulant solution (trisodium citrate 1.765 g, NaCl 3.978 g, EDTA 0.744 g, distilled water 200 mL; pH 7.55) at a ratio of 1:2 (hemolymph: anticoagulant) for subsequent immune response analyses. The population of VpAHPNDRf in the hepatopancreas and intestine was determined by culture-based enumeration. Approximately 0.1 g of tissue was homogenized in PBS at a ratio of 1:9 (w/v). The homogenate was serially diluted and spread onto TCBS supplemented with rifampicin (50 µg mL−1). After incubation for 24 h at 28–30 °C, colonies within the countable range (30–300 colonies) were enumerated and expressed as colony-forming units (CFU g−1 of tissue) according to standard procedures [77]. Tissue samples for histopathological examination were collected from three shrimp per treatment at 36 h post-infection (hpi). The whole hepatopancreas and intestine were aseptically dissected, immediately fixed in Davidson’s solution, and processed according to standard histological procedures for the evaluation of AHPND-associated lesions. Parameters of observation Mortality and mean time to death Mortality rate and mean time to death (MTD) were evaluated during the pathogenicity test. Mortality was calculated as the percentage of shrimp that died relative to the initial number of shrimp stocked. The pathogenicity of each VpAHPND isolate was assessed based on cumulative mortality during the observation period. MTD was calculated from the time of death and the number of shrimp that died at each observation interval [68]. Identification of virulence gene profile Bacteria reisolated from infected shrimp were cultured on CHROMagar™ Vibrio supplemented with rifampicin (50 µg mL−1) and incubated for 24 h at 28–30 °C. A single colony was subsequently cultured in Tryptic Soy Broth (TSB; HiMedia, India) supplemented with 2% NaCl for 24 h at 28–30 °C. Genomic DNA was extracted using a Genomic DNA Mini Kit Bacteria (Geneaid, Taiwan) according to the manufacturer’s instructions. Virulence-associated genes were identified by PCR using primers targeting AP4, pirA, pirB, ToxR, T6SS1, and T6SS2 (Table 1). Table 1Confirmation of virulence-related gene sequences and target amplicons of VpAHPND.GeneSequence (5’-3′)PCR ProductReferenceAP41F:R:ATGAGTAACAATATAAAACATGAAACACGATTTCGACGTTCCCCAA1.269 bp[63]AP42F:R:TGAGAATACGGGACGTGGGGTTAGTCATGTGAGCACCTTC230 bp[63]pirAF:R:TGACTATTCTCACGATTGGACTGCACGACTAGCGCCATTGTTA284 bp[69]pirBF:R:TGATGAAGTGATGGGTGCTCTGTAAGCGCCGTTTAACTCA392 bp[69]toxRF:R:GAAGCAGCACTCACCGATGGTGAAGACTCATCAGCA359 bp[70]T6SS1F:R:GTATTAGACACGTTGCCATCATCTGCTTGCCTCATTCG151 bp[71]T6SS2F:R:TAAAGGTGAAGCGACAGCGAATCATATAGGCGTGTTGC137 bp[71]Abbreviations: AP4 = AHPND plasmid gene 4; pirA = Photorhabdus insect-related toxin A; pirB = Photorhabdus insect-related toxin B; toxR = regulatory gene; T6SS1 = type VI secretion system 1; T6SS2 = type VI secretion system 2. Confirmation of virulence-related gene sequences and target amplicons of VpAHPND. Abbreviations: AP4 = AHPND plasmid gene 4; pirA = Photorhabdus insect-related toxin A; pirB = Photorhabdus insect-related toxin B; toxR = regulatory gene; T6SS1 = type VI secretion system 1; T6SS2 = type VI secretion system 2. Clinical signs Clinical signs were assessed based on the presence of pale hepatopancreas, stomach discoloration, empty gut, melanization, and anorexia according to Kumar et al. [2]. Each sign was scored according to severity as absent (0), mild (1), moderate (2), or severe (3). The scores were summed to obtain the Practical Scoring System (PSS) value. Shrimp condition was classified as normal (0), mild (1–4), or severe (≥5). The PSS value was used to monitor the progression of clinical signs, compare virulence among isolates, and evaluate the diagnostic performance for AHPND through sensitivity, specificity, and likelihood ratio calculations, with a cutoff value of PSS ≥5 as a presumptive indicator of infection [72]. Immune response parameter The immune response parameters evaluated in the pathogenicity and immunogenicity assays included total hemocyte count (THC), phagocytic activity (PA), respiratory burst (RB), and phenoloxidase (PO). THC was counted using a hemocytometer under a light microscope at 100× magnification [73]. PA was determined by the percentage of cells performing phagocytosis in a suspension of Staphylococcus aureus bacteria (10⁷ cells mL−1) incubated for 20 min. The preparation was fixed with absolute methanol and stained with 10% Giemsa for 15 min. Observations were made using a microscope at 400× magnification [74]. RB activity was measured by observing the reduction of NBT (nitroblue tetrazolium 0.3% solution) in 10 μL of hemolymph, then washed gradually with methanol. The formed formazan precipitate was then dissolved in KOH and DMSO, and its absorbance was read at a wavelength of 630 nm [75]. PO activity was determined by first centrifuging the hemolymph to obtain the hemocyte pellet, which was then suspended in citrate buffer. The cell suspension was incubated with trypsin and L-DOPA, and the absorbance was measured at 490 nm using a microplate reader [76]. Bacterial population of VpAHPNDRf The population of VpAHPNDRf bacteria in the hepatopancreas and intestine was determined by culture-based enumeration. Tissue samples were aseptically homogenized in sterile PBS, serially diluted, and spread onto TCBS agar supplemented with rifampicin (50 µg mL−1). After incubation for 24 h at 28–30 °C, colonies within the countable range (30–300 colonies) were enumerated and expressed as colony-forming units (CFU) according to standard procedures [77]. Histopathological analysis Fixed tissue samples were dehydrated through a graded ethanol series, cleared in xylene, embedded in paraffin, sectioned at 4–5 μm, and mounted on glass slides according to standard crustacean histology procedures [78]. Tissue sections were stained with hematoxylin and eosin (H&E) and examined under a light microscope (Olympus CX31) at 400× magnification. Histopathological evaluation focused on characteristic AHPND lesions, including epithelial degeneration, epithelial sloughing, hemocyte infiltration, tubule shrinkage, and necrosis of hepatopancreatic tubules [3]. Survival rate in protection assay Protective efficacy was evaluated based on survival rate (SR) and relative percent survival (RPS) following homologous and heterologous challenge tests. SR was calculated as the percentage of shrimp remaining alive at the end of the observation period relative to the initial number stocked [79]. Relative percent survival was calculated as the reduction in mortality of vaccinated shrimp relative to the mortality observed in the unvaccinated control group [42]. Statistical analyses The qualitative data, including bacterial characteristics and histopathological observations, were analyzed descriptively. Data from the pathogenicity assay, including mortality, MTD, immune response parameters, bacterial population, and survival rate (SR), were analyzed using one-way analysis of variance (ANOVA) using SPSS version 20. Significant differences among treatments were further evaluated using Duncan’s multiple range test at a 95% confidence level (P < 0.05). Survival data were additionally analyzed using the Kaplan–Meier method to evaluate temporal survival patterns among shrimp challenged with different VpAHPND isolates. Survival curves were compared using the log-rank (Mantel–Cox) test. Kaplan–Meier and log-rank analyses were performed using GraphPad Prism version 11 (GraphPad Software, San Diego, CA, USA) individual shrimp survival records, whereas replicate aquaria were retained as the experimental units for ANOVA-based analyses. Data from the immunogenicity and protection assays, including immune response parameters, survival rate (SR), and relative percent survival (RPS), were analyzed using two-way ANOVA using SPSS version 20 to evaluate the effects of vaccine type, isolate type, and their interaction. Significant differences among treatments were further evaluated using Duncan’s multiple range test at a 95% confidence level (P < 0.05). Results Biochemical characteristics and phylogenetic tree Biochemical profiling showed that all isolates shared characteristics consistent with V. parahaemolyticus with a 99.9% similarity level (Table 2). All isolates tested positive for LDC, ODC, indole, gelatinase, and oxidase, and were able to utilize citrate and ferment glucose, mannose, and arabinose. Conversely, all isolates tested negative for ONPG, ADH, H₂S, urease, TDA, and VP tests and could not utilize certain carbon sources such as inositol, sorbitol, rhamnose, sucrose, melibiose, and amygdalin. Phylogenetic analysis based on the 16S rRNA gene sequences (Fig. 1) grouped all Indonesian isolates (TSK, STD, BYW, and IND) within the V. parahaemolyticus lineage together with reference strains from several countries, confirming their taxonomic identity. Isolate IND clustered closely with the V. parahaemolyticus reference strain from China (MN581914), with a bootstrap support of 95%, indicating a close evolutionary relationship. Meanwhile, isolates TSK, STD, and BYW formed a moderately supported subclade (bootstrap = 96%), suggesting that these isolates share a relatively close genetic relationship. Overall, the Indonesian isolates did not form a single exclusive monophyletic clade, indicating the presence of genetic diversity among the circulating V. parahaemolyticus isolates. The outgroup, Bacillus subtilis, was clearly separated from the Vibrio cluster, providing an appropriate root for the phylogenetic tree. Table 2Biochemical characteristics of VpAHPND bacteria.CharacteristicType of IsolateTSKBYWINDSTDOrtho-Nitrophenyl-β-galactopyranoside (ONPG)----Arginine Dihydrolase (ADH)----Lysine decarboxylase (LDC)++++Ornithine decarboxylase (ODC)++++Citrate (CIT)++++H2S----Urease (URE)----Tryptophan deaminase (TDA)----Indole (IND)++++Voges–Proskauer (VP)----Gelatin (GEL)++++Glucose (GLU)++++Mannose (MAN)++++Inositol (INO)----Sorbitol (SOR)----Rhamnose (RHA)----Sucrose (SAC)----Melibiose (MEL)----Amygdalin (AMY)----Arabinose (ARA)++++Oxidase (OX)++++Identification Results (%)99.999.999.999.9Abbreviations: TSK = Tasikmalaya; BYW = Banyuwangi; IND = Indramayu; STD = Situbondo. Biochemical characteristics of VpAHPND bacteria. Abbreviations: TSK = Tasikmalaya; BYW = Banyuwangi; IND = Indramayu; STD = Situbondo. 16S rRNA gene-based phylogenetic tree of V. parahaemolyticus isolates and reference Vibrio strains. The sequences generated in this study have been deposited in GenBank under accession numbers PZ623429 (BYW), PZ623433 (IND), PZ705271 (TSK), and PZ705272 (STD). Mortality and mean time to death The results showed that the BYW isolate produced the highest mortality (87.5%), followed by IND (75%), TSK (60%), and STD (42.5%), while the control group experienced no deaths. The mean time to death (MTD) value indicated that infection by isolate BYW caused the fastest death (28.92 h), while isolate STD had the slowest time to death (56.40 h). Isolates TSK (43.59 h) and IND (39.54 h) were in the middle range and not significantly different, but both showed a faster death rate compared to STD (Table 3). Table 3Mortality and MTD of shrimp in various isolates of VpAHPND.TreatmentMortality (%)MTD (hour)Isolate TSK60.00±8.16bc43.59±8.18bIsolate BYW87.50±9.57d28.92±4.55bIsolate IND75.00±5.77c39.54±8.67bIsolate STD42.50±5.00b56.40±5.71cControl0.00±0.00a0.00±0.00aAbbreviations: TSK = Tasikmalaya isolate; BYW = Banyuwangi isolate; IND = Indramayu isolate; STD = Situbondo isolate; Control = uninfected shrimp (PBS-injected). Values are presented as mean ± SD (n = 4 replicate aquaria per treatment). Different superscript letters indicate in the same column significant differences among treatments (Duncan’s test, P < 0.05). Mortality and MTD of shrimp in various isolates of VpAHPND. Abbreviations: TSK = Tasikmalaya isolate; BYW = Banyuwangi isolate; IND = Indramayu isolate; STD = Situbondo isolate; Control = uninfected shrimp (PBS-injected). Values are presented as mean ± SD (n = 4 replicate aquaria per treatment). Different superscript letters indicate in the same column significant differences among treatments (Duncan’s test, P < 0.05). Survival probability of shrimp challenged with different VpAHPND isolates Kaplan–Meier survival analysis revealed significant differences in survival probability among shrimp challenged with different VpAHPND isolates (Fig. 2). The survival curves differed significantly according to the log-rank (Mantel-Cox) test (χ² = 93.78, df = 4, p < 0.0001). Shrimp challenged with the BYW isolate exhibited the most rapid decline in survival probability, followed by IND and TSK. In contrast, shrimp challenged with the STD isolate maintained a higher survival probability throughout the observation period. No mortality was observed in the negative control group. Kaplan–Meier survival curves of Litopenaeus vannamei challenged with different VpAHPND isolates during a 168 h observation period. Survival curves were significantly different among treatments according to the log-rank (Mantel–Cox) test (χ2 = 93.78, df = 4, p < 0.0001). Survival curves were generated from shrimp maintained in four replicate aquaria per treatment (n = 4; 10 shrimps per aquarium). TSK = Tasikmalaya isolate; BYW = Banyuwangi isolate; IND = Indramayu isolate; STD = Situbondo isolate; control = uninfected shrimp (PBS-injected). Virulence gene profiles of VpAHPND isolates The virulence gene detection results showed variation in the presence of the pirA and pirB toxin genes. All isolates confirmed positive for the AHPND marker gene (AP4). The pirA and pirB genes were only detected in isolates BYW and IND, while they were not found in isolates TSK and STD. All isolates showed positive amplification for the toxR, T6SS1, and T6SS2 genes (Table 4). The electropherogram of virulence gene detection in bacterial isolates is shown in Fig. 3. Table 4Virulence profile of various VpAHPND bacterial isolates.Virulence GeneGene Detection Results on Bacterial IsolateTSKBYWINDSTDAP4++++pirA-++-pirB-++-toxR++++T6SS1++++T6SS2++++Abbreviations: TSK = Tasikmalaya isolate; BYW = Banyuwangi isolate; IND = Indramayu isolate; STD = Situbondo isolate; AP4 = AHPND plasmid gene 4; pirA = Photorhabdus insect-related toxin A; pirB = Photorhabdus insect-related toxin B; toxR = regulatory gene; T6SS1 = type VI secretion system 1; T6SS2 = type VI secretion system 2. Virulence profile of various VpAHPND bacterial isolates. Abbreviations: TSK = Tasikmalaya isolate; BYW = Banyuwangi isolate; IND = Indramayu isolate; STD = Situbondo isolate; AP4 = AHPND plasmid gene 4; pirA = Photorhabdus insect-related toxin A; pirB = Photorhabdus insect-related toxin B; toxR = regulatory gene; T6SS1 = type VI secretion system 1; T6SS2 = type VI secretion system 2. The electropherogram of virulence gene detection in bacterial isolates. M = Marker; TSK = Tasikmalaya isolate; BYW = Banyuwangi isolate; IND = Indramayu isolate; STD = Situbondo isolate; NC = negative control; PC = positive control. Clinical signs Clinical signs in infected shrimp included pale discoloration of the hepatopancreas and stomach, an empty gut, and melanization observed in some external body regions (Fig. 4). The highest PSS values were observed in isolates BYW (11.71±1.60) and IND (10.86±2.04), indicating a high severity of clinical signs. Isolates TSK (4.86±1.95) and STD (3.14±1.46) were categorized as low, indicating mild clinical symptoms, while the control group showed no signs (0.00) (Table 5). Diagnostic analysis showed that the PSS had a sensitivity of 93.33% and a specificity of 94.11%, with a positive likelihood ratio (+LR) of 15.87, indicating strong evidence of typical AHPND signs, and a negative likelihood ratio (−LR) of 0.01, indicating strong evidence for the absence of AHPND signs (Table 6). Clinical signs of shrimp infected with VpAHPND. A1 = normal shrimp; A2 = infected shrimp; B1 = hepatopancreas and intestine of healthy shrimp; B2 = hepatopancreas and intestine of infected shrimp. H = hepatopancreas; I = intestine; S = stomach; M = melanization. Images are representative of observations from four replicate aquaria. Table 5Practical Scoring System (PSS) values across different isolates during 7 days of observation.TreatmentPractical Scoring System (PSS)CategoryTSK4.86±1.95MildBYW11.71±1.60SevereIND10.86±2.04SevereSTD3.14±1.46MildControl0.00±0.00NormalAbbreviations: TSK = TSK isolate; BYW = BYW isolate; IND = IND isolate; STD = STD isolate; Control = uninfected shrimp (PBS-injected). (n = 4 aquaria per treatment). Practical Scoring System (PSS) values across different isolates during 7 days of observation. Abbreviations: TSK = TSK isolate; BYW = BYW isolate; IND = IND isolate; STD = STD isolate; Control = uninfected shrimp (PBS-injected). (n = 4 aquaria per treatment). Table 6Diagnostic performance of the Practical Scoring System (PSS) for AHPND indication.ParameterValueSensitivity (%)93.30Specificity (%)94.11Positive Likelihood Ratio (+LR)15.87Negative Likelihood Ratio (-LR)0.01 Diagnostic performance of the Practical Scoring System (PSS) for AHPND indication. Immune response of pathogenicity assay Immune responses showed significant differences among post-infection isolates (Fig. 5). The initial THC did not differ among treatments (P > 0.05). Still, it decreased on day 1, especially in isolates BYW, IND, and TSK, which were significantly lower compared to STD and the control (P < 0.05). Subsequently, THC in isolates TSK and STD increased more rapidly, while BYW and IND remained low until day 5 before increasing on day 7, when all treatments showed higher values compared to the control. PA increased significantly on day 1 in isolates BYW and IND, and was higher in TSK and STD compared to the control. The PA increase continued until day 5, with the highest values in BYW and IND, and on day 7, all isolates (TSK, BYW, IND) showed higher activity than STD and the control. RB showed an initial decrease on day one in all treatments, then gradually increased. Isolate BYW exhibited the highest RB activity, especially on day 7, followed by IND, while TSK and STD did not differ significantly from the control. PO activity also decreased on day 1 in isolates TSK, BYW, and IND, but gradually increased until day 7. The largest PO increase was observed in isolates TSK and STD, followed by BYW and IND, with all treatments exceeding the control at the end of the observation period. Total haemocyte count (THC), phagocytic activity (PA), respiratory burst (RB), and phenoloxidase (PO) activity in the pathogenicity assay. Shrimp were injected with different isolates of VpAHPND for 7 days. Data are presented as mean ± SD (n = 4 biological replicates per treatment per sampling time). Different letters indicate significant differences (P < 0.05) among treatments on the same observation day. TSK = Tasikmalaya isolate; BYW = Banyuwangi isolate; IND = Indramayu isolate; STD = Situbondo isolate; control = uninfected shrimp (PBS-injected). Population of VpAHPNDRf The total population of VpAHPNDRf in the intestine and hepatopancreas showed different dynamics among isolates during the observation period (Table 7). In the intestinal organ, the highest bacterial population on day 1 was observed in the IND isolate, followed by BYW, TSK, and STD. The populations of all isolates increased on day 3, with IND remaining the highest, while BYW and STD showed no significant difference. On day 5, the populations of BYW, IND, and STD did not differ significantly and were higher than those of TSK. By day 7, bacterial populations in all isolates tended to be uniform. In the hepatopancreas, isolate IND showed the highest population on day 1. All isolates experienced an increase on day 3, with BYW and IND being higher than TSK and STD. From days 5 to 7, isolate BYW exhibited the highest bacterial population among the isolates. Table 7Bacterial population in the gut of shrimp infected with various isolates.OrganTreatmentTime (day)1357Intestine (Log CFU g−1)TSK5.34±0.16c5.74±0.07b4.47±0.14b4.66±0.11bBYW5.53±0.17d6.48±0.08c5.74±0.08c4.57±0.15bIND6.82±0.06e6.67±0.04d5.76±0.04c4.64±0.12bSTD4.33±0.14b6.37±0.25c5.60±0.20c4.69±0.08bControl0.00±0.00a0.00±0.00a0.00±0.00a0.00±0.00aHepatopancreas (Log CFU g−1)TSK3.60±0.15b4.56±0.15b3.66±0.35b3.53±0.03cBYW4.43±0.18c5.66±0.12c5.57±0.31d4.51±0.13dIND4.65±0.11d5.68±0.14c4.60±0.16c4.57±0.11dSTD3.46±0.20b4.52±0.25b3.77±0.12b2.47±0.21bControl0.00±0.00a0.00±0.00a0.00±0.00a0.00±0.00aAbbreviations: TSK = Tasikmalaya; BYW = Banyuwangi; IND = Indramayu; STD = Situbondo; Control = uninfected shrimp (PBS-injected). Values are presented as mean ± SD (n = 4 replicate aquaria per treatment). Different superscript letters indicate in the same column significant differences among treatments (Duncan’s test, P < 0.05). Bacterial population in the gut of shrimp infected with various isolates. Abbreviations: TSK = Tasikmalaya; BYW = Banyuwangi; IND = Indramayu; STD = Situbondo; Control = uninfected shrimp (PBS-injected). Values are presented as mean ± SD (n = 4 replicate aquaria per treatment). Different superscript letters indicate in the same column significant differences among treatments (Duncan’s test, P < 0.05). Histological analysis The intestinal and hepatopancreatic tissues of healthy shrimp exhibited normal histological architecture, with epithelial structure, tissue layers, and tubules arranged neatly and showing no signs of damage (Fig. 6). In the intestine, infection by BYW and IND isolates caused the most noticeable damage, characterized by extensive necrosis of the epithelium, accompanied by cell detachment into the lumen, as well as swelling and congestion in the submucosal layer and changes in the muscle layer. The TSK isolate showed more limited damage, marked by partial necrosis of the epithelium and tissue swelling, while some structures remain relatively preserved. The STD isolate caused milder changes, mainly characterized by epithelial cell degeneration with tissue structures still largely maintaining their normal shape (Fig. 7). In the hepatopancreas, all isolates caused structural changes in the tubules, but with different patterns. The BYW isolate showed damage characterized by epithelial cell proliferation, tissue necrosis, and debris accumulation in the lumen. The IND and TSK isolates also caused necrosis and cell swelling, leading to narrowing of the tubule lumen. Meanwhile, the STD isolate caused more changes in the form of degeneration and cell proliferation, with some tubules experiencing lumen dilation (Fig. 8). H&E-stained photomicrographs of intestine (A1–A2) and hepatopancreas (B1–B2) of Litopenaeus vannamei without bacterial injection (control). A1 = no observable alterations; A2 = tunica mucosa (TM), tunica submucosa (TSM), tunica muscularis (TMC), epithelium (E). B1 = no observable alterations; closely packed intertubular spaces (black arrows), tubules without alterations (red arrows). B2 = tubules (T), lumen (L), vesicles (V), nucleus (N). Representative histological sections from three shrimp per treatment. H&E-stained photomicrographs of the intestine following infection with different bacterial isolates. Tunica mucosa (TM), tunica submucosa (TSM), tunica muscularis (TMC), epithelium (E). (TSK) E = necrosis; TMC = nuclear necrosis; TSM = swelling and congestion. (BYW) All layers exhibited necrosis. (IND) All layers exhibited necrosis. (STD) E = necrosis; TMC = nuclear necrosis; TSM = swelling. Representative histological sections from three shrimp per treatment. H&E-stained photomicrographs of the hepatopancreas of shrimp infected with different bacterial isolates. Intertubular spacing (T) was moderately expanded (black arrows), elongated across most regions (blue arrows), and showed widespread morphological alterations (red arrows). Tubules (T), lumen (L), vesicles (V), nucleus (N). (TSK) V = necrosis and hyperplasia; N = necrosis and hyperplasia; T = extensive alteration; L = constricted. (BYW) V = hyperplasia; N = necrosis; T = extensive alteration; L = presence of deposits. (IND) V = necrosis and hyperplasia; N = necrosis and hyperplasia; T = extensive alteration; L = constricted. (STD) V = hyperplasia; N = degeneration and hyperplasia; T = partially altered; L = dilated. Representative histological sections from three shrimp per treatment. Immune response of the immunogenicity assay Immune response parameters increased following vaccination, with differences among treatments (Fig. 9). The initial THC was not different among groups (P > 0.05), but increased on day 1 in all vaccine treatments, with the highest values in V-BYW and V-IND. On day 3, THC among treatments was not significantly different but remained higher than the control, while on day 5, there was a decrease in V-STD. On day 7, V-BYW maintained the highest THC values. PA showed a similar pattern, with increases from day 1 to day 3 in all vaccine groups, especially in V-BYW and V-IND. This activity remained high until day 7, with V-BYW showing the highest values compared to other treatments and the control. RB and PO also increased after vaccination. The highest RB values were observed in V-BYW and V-IND starting from day 3 and persisted until day 7, while V-TSK and V-STD tended to decrease on day 5. PO activity increased in all treatments, with the highest values in V-BYW until day 5, then tended to decrease on day 7. Total haemocyte count (THC), phagocytic activity (PA), respiratory burst (RB), and phenoloxidase (PO) activity in immunogenicity assay. Shrimp were vaccinated with different VpAHPND inactivated isolates, and immune responses were evaluated over 7 days before the challenge test. Data are presented as mean ± SD (n = 3 biological replicates per treatment per sampling time). Different letters indicate significant differences (P < 0.05) among treatments on the same observation day. TSK = Tasikmalaya isolate; BYW = Banyuwangi isolate; IND = Indramayu isolate; STD = Situbondo isolate; control = unvaccinated shrimp (PBS-injected). Survival rate of protection assay The results of the vaccine protection test showed differences in survival rates among treatments (Table 8, Table 9, Table 10, Table 11). Statistical analysis indicated that the type of vaccine, type of isolate, and their interaction significantly affected shrimp survival (P < 0.05). Generally, vaccinated shrimp exhibited higher survival rates compared to unvaccinated ones. Vaccines prepared from the BYW isolate (V-BYW) and IND (V-IND) produced the highest survival rates and were not significantly different from each other, but both were higher than V-TSK and V-STD. Based on the isolate type, infections by BYW, IND, and TSK showed relatively similar survival rates, but lower than those of STD. Interaction analysis showed that the combination of the same vaccine and isolate (homologous) resulted in the highest survival rates, especially in the V-BYW treatment challenged with the BYW isolate. Conversely, the lowest survival was observed in unvaccinated shrimp challenged with the BYW isolate. Table 8Survival rate (SR) of shrimp vaccinated with different VpAHPND isolates after homologous and heterologous challenges.Factor AFactor B (Type of Bacteria)(Type of Vaccine)TSKBYWINDSTDV-TSK62.50±5.0040.00±8.1645.00±5.7857.50±5.00V-BYW65.00±5.8067.50±5.0060.00±8.1662.50±9.57V-IND50.00±8.2060.00±8.1665.00±5.7760.00±8.16V-STD47.5±9.6045.00±5.7740.00±8.1655.00±5.77Positive Control40.00±8.2027.50±5.0032.50±9.5742.50±5.00Negative Control100.00±0.00100.00±0.00100.00±0.00100.00±0.00Abbreviations: V-TSK = vaccine derived from TSK isolate; V-BYW = vaccine derived from BYW isolate; V-IND = vaccine derived from IND isolate; V-STD = vaccine derived from Situbondo isolate; positive control = challenged without vaccination; negative control = unchallenged and non-vaccinated. TSK = Tasikmalaya; BYW = Banyuwangi; IND = Indramayu; STD = Situbondo. Values are presented as mean ± SD (n = 4 replicate aquaria per treatment). Survival rate (SR) of shrimp vaccinated with different VpAHPND isolates after homologous and heterologous challenges. Abbreviations: V-TSK = vaccine derived from TSK isolate; V-BYW = vaccine derived from BYW isolate; V-IND = vaccine derived from IND isolate; V-STD = vaccine derived from Situbondo isolate; positive control = challenged without vaccination; negative control = unchallenged and non-vaccinated. TSK = Tasikmalaya; BYW = Banyuwangi; IND = Indramayu; STD = Situbondo. Values are presented as mean ± SD (n = 4 replicate aquaria per treatment). Table 9Relative percent survival (RPS) of shrimp vaccinated with different VpAHPND isolates following homologous and heterologous challenge tests.Factor AFactor B (Type of Bacteria)(Type of Vaccine)TSKBYWINDSTDV-TSK37.50±8.3317.24±7.9618.52±8.5526.09±8.70V-BYW41.67±9.6262.07±7.9640.74±12.1034.78±10.04V-IND16.67±9.6242.86±8.2553.57±13.6833.33±9.62V-STD25.00±11.7921.43±8.2514.29±8.2525.00±9.62Abbreviations: V-TSK = vaccine derived from TSK isolate; V-BYW = vaccine derived from BYW isolate; V-IND = vaccine derived from IND isolate; V-STD = vaccine derived from Situbondo isolate. TSK = Tasikmalaya; BYW = Banyuwangi; IND = Indramayu; STD = Situbondo. Values are presented as mean ± SD (n = 4 replicate aquaria per treatment). Relative percent survival (RPS) of shrimp vaccinated with different VpAHPND isolates following homologous and heterologous challenge tests. Abbreviations: V-TSK = vaccine derived from TSK isolate; V-BYW = vaccine derived from BYW isolate; V-IND = vaccine derived from IND isolate; V-STD = vaccine derived from Situbondo isolate. TSK = Tasikmalaya; BYW = Banyuwangi; IND = Indramayu; STD = Situbondo. Values are presented as mean ± SD (n = 4 replicate aquaria per treatment). Table 10Results of the further survival test of shrimp based on factor A (type of vaccine).Comparison of TreatmentP-ValueConclusionV-BYW and Positive Control0.0000000Significantly differentV-IND and Positive Control0.0000000Significantly differentV-STD and Positive Control0.0008826Significantly differentV-TSK and Positive Control0.0000025Significantly differentV-BYW and V-IND0.2376116Not significantly differentV-BYW and V-STD0.0000001Significantly differentV-BYW and V-TSK0.0000340Significantly differentV-IND and V-STD0.0001798Significantly differentV-IND and V-TSK0.0293730Significantly differentV-STD and V-TSK0.4870445Not significantly differentAbbreviations: V-TSK = vaccine derived from TSK isolate; V-BYW = vaccine derived from BYW isolate; V-IND = vaccine derived from IND isolate; V-STD = vaccine derived from STD isolate; positive control = challenged without vaccination. Results of the further survival test of shrimp based on factor A (type of vaccine). Abbreviations: V-TSK = vaccine derived from TSK isolate; V-BYW = vaccine derived from BYW isolate; V-IND = vaccine derived from IND isolate; V-STD = vaccine derived from STD isolate; positive control = challenged without vaccination. Table 11Results of the further survival test of shrimp based on factor B (isolate type).Comparison of TreatmentP-ValueConclusionBYW and IND1.00000000Not significantly differentBYW and STD0.04332690Significantly differentBYW and TSK0.35256480Not significantly differentIND and STD0.04332690Significantly differentIND and TSK0.35256480Not significantly differentSTD and TSK0.72744890Not significantly differentAbbreviations: TSK = Tasikmalaya isolate; BYW = Banyuwangi isolate; IND = Indramayu isolate; STD = Situbondo isolate. Results of the further survival test of shrimp based on factor B (isolate type). Abbreviations: TSK = Tasikmalaya isolate; BYW = Banyuwangi isolate; IND = Indramayu isolate; STD = Situbondo isolate. Vaccinated shrimp showed higher RPS values than unvaccinated shrimp across all challenge tests (Table 8, Table 9, Table 10, Table 11, Table 12). The highest RPS values were recorded in homologous vaccination-challenge combinations, particularly in the V-BYW treatment challenged with the BYW isolate. In contrast, lower RPS values were generally observed in heterologous challenge combinations. Among the vaccine treatments, V-BYW and V-IND consistently produced higher RPS values than V-TSK and V-STD. Table 12Results of further testing of the interaction between factor A (type of vaccine) and factor B (type of bacterial isolate).NoFactor AFactor BMeanSEdfLower.CLUpper.CLNotation1Positive ControlBYW2.750.380515601.5521683.947832a2Positive ControlIND3.250.380515602.0521684.447832ab3TSKBYW4.000.380515602.8021685.197832abc4Positive ControlTSK4.000.380515602.8021685.197832abc5STDIND4.000.380515602.8021685.197832abc6Positive ControlSTD4.250.380515603.0521685.447832abcd7STDBYW4.500.380515603.3021685.697832abcde8TSKIND4.500.380515603.3021685.697832abcde9STDTSK4.750.380515603.5521685.947832bcdef10INDTSK5.000.380515603.8021686.197832bcdefg11STDSTD5.500.380515604.3021686.697832cdefgh12TSKSTD5.750.380515604.5521686.947832cdefgh13INDSTD6.000.380515604.8021687.197832defgh14INDBYW6.000.380515604.8021687.197832defgh15BYWIND6.000.380515604.8021687.197832defgh16BYWSTD6.250.380515605.0521687.447832efgh17TSKTSK6.250.380515605.0521687.447832efgh18BYWTSK6.500.380515605.3021687.697832fgh19INDIND6.750.380515605.5521687.947832gh20BYWBYW7.250.380515606.0521688.447832hAbbreviations: Factor A = vaccine type; Factor B = isolate type. V-TSK = vaccine from TSK isolate; V-BYW = vaccine from BYW isolate; V-IND = vaccine from IND isolate; V-STD = vaccine from STD isolate; positive control = challenged, unvaccinated shrimp. TSK = Tasikmalaya isolate; BYW = Banyuwangi isolate; IND = Indramayu isolate; STD = Situbondo isolate. Different superscript letters among factor interactions indicate significant differences (P < 0.05). Results of further testing of the interaction between factor A (type of vaccine) and factor B (type of bacterial isolate). Abbreviations: Factor A = vaccine type; Factor B = isolate type. V-TSK = vaccine from TSK isolate; V-BYW = vaccine from BYW isolate; V-IND = vaccine from IND isolate; V-STD = vaccine from STD isolate; positive control = challenged, unvaccinated shrimp. TSK = Tasikmalaya isolate; BYW = Banyuwangi isolate; IND = Indramayu isolate; STD = Situbondo isolate. Different superscript letters among factor interactions indicate significant differences (P < 0.05). Discussion The pathogen causing AHPND was first identified as the bacterium V. parahaemolyticus (VpAHPND) carrying the binary PirAB toxin [3]. This discovery became the primary basis for developing AHPND control strategies, including the application of vaccine technology [23,80]. The use of local isolates as vaccine candidates can reflect the antigenic diversity of bacteria present in a given region, thereby providing more optimal protection due to ecological relevance [81]. Four local isolates in this study were identified as VpAHPND by PCR with AP4 primers. Biochemical profiles further confirmed that all isolates showed positive reactions for indole, oxidase, lysine decarboxylase, and gelatinase, consistent with the characteristics of V. parahaemolyticus reported in previous studies [82]. Phylogenetic analysis based on the 16S rRNA gene demonstrated that all Indonesian isolates were grouped within the VpAHPND lineage together with reference strains from several countries, confirming their species identity. Isolate IND clustered closely with the Chinese reference strain (MN581914), whereas isolates TSK, STD, and BYW formed a moderately supported subclade, indicating a relatively close genetic relationship among these three Indonesian isolates. However, the Indonesian isolates did not form a single exclusive monophyletic clade, suggesting the presence of genetic diversity among VpAHPND isolates circulating in Indonesia. Such genetic diversity may reflect the circulation of multiple lineages or independent evolutionary histories within the Indonesian VpAHPND population. Nevertheless, because the phylogenetic analysis was based on the highly conserved 16S rRNA gene, the observed relationships should primarily be interpreted as evidence of taxonomic relatedness rather than differences in pathogenicity or virulence. The AHPND status of the isolates was therefore determined based on the detection of AHPND-associated virulence genes rather than on 16S rRNA phylogeny [55,58]. Pathogenicity tests demonstrated differences in virulence levels among bacterial isolates. Isolates BYW and IND caused the highest mortality and were confirmed to carry the pirA and pirB genes. In contrast, isolates TSK and STD, which were negative for both genes, resulted in lower shrimp mortality. Tran et al. [3] and Lee et al. [5] reported that high virulence in VpAHPND is associated with the presence of pirA and pirB toxin genes. Differences in virulence were also reflected in the MTD, where shrimp injected with BYW and IND died more rapidly. Faster clinical progression and higher severity further confirmed that BYW and IND are more virulent than TSK and STD. The Kaplan–Meier survival analysis provided additional evidence of differences in pathogenicity among the VpAHPND isolates. The rapid decline in survival observed in shrimp challenged with the BYW isolate indicates a higher infection pressure and greater virulence compared with the other isolates. Conversely, the slower decline in survival associated with the STD isolate is consistent with its lower cumulative mortality and longer MTD. These findings support the pathogenicity assessment and further demonstrate the heterogeneity in virulence among the tested isolates. Diagnostic analysis reinforced the indication that observed clinical signs were associated with AHPND, as reported by Kumar et al. [2] and Chandran et al. [7]. Although isolates TSK and STD were confirmed as VpAHPND using AP4 detection [63], results from specific primer detection [69] indicated that they did not carry the pirA/pirB genes. This discrepancy suggests loss or alteration of the pirA/pirB region within the pVA1 plasmid, rendering the toxin non-functional [70]. The mortality caused by TSK and STD is therefore likely mediated by alternative virulence factors such as toxR and the Type VI secretion systems (T6SS1 and T6SS2), which were detected in all isolates [58]. The toxR gene functions as a major transcriptional regulator controlling bacterial virulence gene expression, while T6SS plays a role in bacterial competition and host colonization [83,84]. The presence of pirAB genes, together with the higher virulence exhibited by BYW and IND, suggests that these isolates may possess antigenic determinants that are relevant for vaccine development. Differences in immune response patterns induced by each isolate indicate differences in antigenicity, a crucial factor for selecting vaccine candidates. Highly virulent isolates (BYW and IND) induced stronger innate immune responses compared to TSK and STD. This was evidenced by increased phagocytic activity and phenoloxidase enzyme activity, along with decreased total hemocyte count (THC) and respiratory burst during the early phase of infection. Increased phagocytic activity and activation of the phenoloxidase system are key indicators of antigen recognition and cellular defense activation in crustaceans [85,86]. The reduction in hemocyte numbers indicates mobilization and intensive utilization of hemocytes toward infection sites as part of the early immune response [87,88]. This stronger immune response suggests that BYW and IND may possess antigenic components capable of eliciting stronger innate immune activation, thereby indicating greater potential as vaccine candidates [1]. The dynamics of bacterial population and tissue damage reflect the ability of isolates to colonize the host and express virulence factors. Isolates BYW and IND exhibited high colonization of the intestine and hepatopancreas, accompanied by typical AHPND lesions, including epithelial cell sloughing and debris accumulation in the tubular lumen, which are associated with the presence of the PirA and PirB toxins as the main virulence factor [89]. This toxin binds to specific receptors such as aminopeptidase-N-like proteins and induces pore formation in cell membranes, leading to cell lysis and apoptosis in the hepatopancreas [90]. In contrast, TSK and STD, which lack pirA/pirB genes, did not exhibit typical tissue damage, although they were still detectable in target organs, indicating lower virulence. High bacterial load and tissue damage in virulent isolates reflect active expression of virulence factors during infection, which also represent antigenic components recognized by the host immune system [91]. Therefore, isolates with strong colonization and virulence, such as BYW and IND, exhibit greater antigenic relevance and may provide an important basis for developing inactivated vaccines [92]. Immunogenicity tests of inactivated vaccines derived from different isolates showed immune response patterns consistent with their respective virulence levels. Vaccines derived from BYW and IND induced stronger immune responses than those derived from TSK and STD. The superior immunogenicity observed in these isolates may be associated with differences in antigenic composition, including the presence of virulence-associated antigens such as PirA/PirB toxins, outer membrane proteins, secretion system components, or other immunostimulatory molecules. Therefore, the enhanced protective efficacy observed in BYW and IND cannot be attributed solely to their higher virulence but may also reflect isolate-specific antigenic characteristics relevant to vaccine-induced protection [30,93]. The PirA/PirB binary toxin is a specific AHPND antigen directly involved in pathogenesis and has been shown to induce immune responses in both native and recombinant forms, making it a primary target for vaccine development [23,28,59]. In addition, outer membrane proteins (OMPs) are conserved surface proteins involved in adhesion and host interaction, making them readily recognized by hemocytes and important in activating phagocytosis and humoral immune responses [53,94,95]. Serine proteases have also been reported as relatively stable and conserved antigens among AHPND strains, thereby enhancing immune responses and prolonging vaccine protection [29,96]. T6SS components, such as Hcp, VgrG, and the VipA/VipB complex, are structural elements involved in T6SS assembly and effector delivery in V. parahaemolyticus [83,97,98]. Their structural and functional roles suggest that T6SS components may represent potential immunogenic targets for further vaccine development. The ability of vaccines derived from BYW and IND to induce stronger immune responses suggests that these isolates potentially possess a broader or more immunogenic repertoire of antigenic determinants, making them promising vaccine candidates. The effectiveness of the induced immune response was associated with the level of protection observed in challenge tests. The survival of shrimp vaccinated with BYW and IND was significantly higher than that of unvaccinated groups and those vaccinated with TSK and STD. This suggests that differences in antigen immunogenicity may contribute to the protective immune response. The relationship between increased immune parameters and survival rate highlights the importance of innate immune activation in enhancing shrimp resistance to bacterial infection [55,30,99]. The highest level of protection observed in homologous challenge with the BYW isolate indicates optimal antigenic matching between the vaccine and the challenge pathogen. Exposure to inactivated pathogens may induce a primed immune state, allowing the innate immune system to respond more rapidly and effectively upon subsequent exposure [50,100]. The BYW vaccine's ability to provide cross-protection against heterologous isolates suggests that it may contain conserved antigenic determinants shared across multiple VpAHPND strains [99]. This phenomenon is consistent with the concept of innate immune priming proposed for invertebrates [57]. The high and broad protection provided by the BYW-based vaccine indicates that this isolate possesses antigenic components that are not only immunogenic but also highly protective in Pacific white shrimp. A limitation of this study is that both vaccination and challenge were performed by intramuscular injection, whereas AHPND naturally occurs through oral exposure to contaminated feed, water, or infected organisms. Injection was used to ensure accurate dose delivery, minimize experimental variation, and allow standardized comparisons of isolate virulence and vaccine efficacy. However, this method bypasses natural mucosal barriers and may not fully represent host–pathogen interactions under farming conditions. Therefore, the protective efficacy observed here should be interpreted within the context of controlled laboratory experiments. Because oral vaccination is more practical for commercial shrimp farming, future studies should evaluate whether the protection induced by the BYW isolate can also be achieved through oral or immersion vaccination. In addition, multilocus sequence analysis (MLSA) or whole-genome sequencing (WGS) would help improve vaccine candidate selection and provide greater insight into isolate-specific protective mechanisms. Overall, the results indicate that the highly virulent BYW and IND isolates are promising candidates for inactivated VpAHPND vaccines. Both isolates carried the pirA/pirB genes, induced stronger innate immune responses, and provided greater protection than the TSK and STD isolates. Among them, BYW showed the highest immunogenicity and protective efficacy, making it the most promising vaccine candidate. However, this study does not suggest that virulence alone determines vaccine efficacy. The superior performance of BYW and IND may also be related to antigenic composition, such as differences in antigen abundance, plasmid content, outer membrane proteins, toxin expression, secretion system components, and other immunogenic factors [30]. Because these antigenic features were not characterized, their contribution to vaccine efficacy could not be determined. Further comparative analyses of the antigenic profiles of VpAHPND isolates are needed to clarify the mechanisms of vaccine-induced protection and support the selection of effective vaccine strains. Conclusion The BYW and IND isolates carrying the pirA and pirB genes exhibited higher virulence, elicited stronger immune responses, and conferred greater protective efficacy than the other tested isolates. Although the present findings indicate an association between isolate virulence and protective efficacy, vaccine performance is likely influenced by multiple antigenic determinants rather than virulence alone. The superior protection observed in the BYW and IND isolates may therefore reflect differences in the composition and immunogenicity of virulence-associated antigens and other immunostimulatory components. Among the isolates evaluated, BYW consistently demonstrated the most favorable immunogenicity and protective performance, highlighting its potential as a promising candidate for the development of an inactivated vaccine against VpAHPND in Pacific white shrimp. Approval of ethics committee This study was approved by the Research Ethics Committee of Hasanuddin University (Approval No. 356/UN4.6.4.5.31/PP36/2025). Declaration of generative AI and AI-assisted technologies in the manuscript preparation process During the preparation of this work, the author(s) used ChatGPT and Grammarly for structuring and translating the text into English. After using these tools/services, the author(s) reviewed and edited the content as needed and take full responsibility for the content of the published article. Financial disclosure This research was funded by the Center for Marine and Fisheries Education, BPPSDM KP, Ministry of Marine Affairs and Fisheries, Republic of Indonesia (No. 28/KEPMEN/KP.532/I/2024). CRediT authorship contribution statement Ardana Kurniaji: Writing – review & editing, Writing – original draft, Project administration, Methodology, Formal analysis, Data curation, Conceptualization. Sri Nuryati: Writing – review & editing, Supervision, Methodology, Formal analysis, Data curation, Conceptualization. Sukenda Sukenda: Writing – review & editing, Validation, Supervision, Conceptualization. Alimuddin Alimuddin: Writing – review & editing, Validation, Supervision. Hasan Nasrullah: Writing – review & editing, Validation, Supervision, Resources, Formal analysis. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Acknowledgment The authors would like to thank the Aquatic Organism Health Laboratory and the Fish Reproduction and Genetics Laboratory, Department of Aquaculture, Faculty of Fisheries and Marine Sciences, IPB University, West Java, Shrimp Hatchery Installation (IPU), Barru Regency, South Sulawesi, Brackishwater Aquaculture Fisheries Research Center and Fisheries Extension (BRPBAP3), Maros, South Sulawesi, for providing facilities and technical support. Data availability Data will be made available on request. References Associated Data Data Availability Statement Data will be made available on request.